glutathione parkinson's disease therapy perlmutter Joel Perlmutter, MD | Neurology Targeting Mitochondria as a Therapeutic
Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease Cellular and Molecular Neurobiology Springer Nature Link Perlmutter named scientific director of dystonia foundation The Source WashU From Bench to Brain: Translating EV and Nanocarrier Research into Parkinson's Disease Therapies Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2 2 and DT Diaphorase Central nervous system uptake of intranasal glutathione in Parkinson's disease npj Parkinson's Disease
Pay in 4 interest-free payments of $7.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




